Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSTG | Common Stock | Exercise of in-the-money or at-the-money derivative security | $600K | +300K | +4889.98% | $2.00 | 306K | Dec 7, 2022 | The spouse of the reporting person | |
transaction | BSTG | Common Stock | Sale | -$600K | -83.7K | -27.33% | $7.17 | 222K | Dec 7, 2022 | The spouse of the reporting person | F1 |
holding | BSTG | Common Stock | 44.5K | Dec 7, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSTG | Warrants (right to buy) | Exercise of in-the-money or at-the-money derivative security | $0 | -300K | -100% | $0.00* | 0 | Dec 7, 2022 | Common Stock | 300K | $2.00 | The spouse of the reporting person | F1 |
Id | Content |
---|---|
F1 | On December 7, 2022, the Spouse of the Reporting Person exercised a warrant to purchase 300,000 shares of common stock for $2 per share. The Spouse of the Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 83,676 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 216,324 shares of common stock. |